Experiment 508837
Worktypes
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | IV |
| Organism | Empty organism |
| Citation | TAMURA,T: SASAKI,Y: EGUCHI,K: SHINKAI,T: OHE,Y: NISHIO,M: KUNIKANE,H: ARIOKA,H: KARATO,A: OMATSU,H: NAKASHIMA,H: SAIJO,N:. (1994). PHASE I AND PHARMACOKINETIC STUDY OF PACLITAXEL BY 24-HOUR INTRAVENOUS INFUSION.. 85(10) |
| Amount utilized | |
| Compound isolated | |
| Disease | PHASE I STUDY OF EFFICACY OF COMPOUND IN TREATING SOLID TUMORS IN 18 PATIENTS. SIDE-EFFECTS INCLUDE CRANULOCYTOPENIA, LIVER DYSFUNCTION, ALOPECIA, PERIPHERAL NEUROPATHY AND MYALGIA. ACTIVITY SEEN IN ONLY ONE PATIENT WITH PULMONARY METASTASES FROM PHARYNGEAL CANCER. |
| Dose amount | 135.0 MG |
| Number | 1 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Per unit | SQ M BODY SURFACE |
| Dose expression | DOSE |